Delhi High Court grants interim relief to Sun Pharma in trademark dispute, restraining Alenvision from selling its NEXADOM medication amidst allegations of infringing on Sun Pharma’s NAXDOM trademark.

Delhi High Court grants interim relief to Sun Pharma in trademark dispute, restraining Alenvision from selling its NEXADOM medication amidst allegations of infringing on Sun Pharma’s NAXDOM trademark.

by | Oct 14, 2025 | Pharma, Sun Pharma

The Delhi High Court has granted interim relief to Sun Pharma in a trademark dispute over the name “NAXDOM”. The court has barred Alenvision from manufacturing and selling a drug called “NEXADOM”, which Sun Pharma claims is deceptively similar...
Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association

Several Indian pharmaceutical companies, including Glenmark, Granules, and Zydus, have issued recalls for certain medications in the US market due to concerns over quality, as reported by the US Food and Drug Administration (USFDA).

by | Sep 28, 2025 | Glenmark, Pharma, Sun Pharma, Zydus

Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, as reported by the US Food and Drug Administration (USFDA). The recalls are related to manufacturing problems, impurities, and labeling errors. Glenmark...
Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association

Several pharmaceutical companies, including Zydus, Sun Pharma, and Glenmark, have issued recalls of their medications in the US due to concerns regarding quality standards.

by | Sep 28, 2025 | Glenmark, Pharma, Sun Pharma, Zydus

Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, including manufacturing problems, impurities, and labeling errors, as reported by the US Food and Drug Administration (USFDA). The recalls affect a range of...